Literature DB >> 3115069

Endotoxin pretreatment enhances neutrophil FMLP-receptor binding and activity in guinea pigs.

U B Olsen, V Bille-Hansen.   

Abstract

Polymorphonuclear leukocytes isolated from endotoxin pretreated (0.1 mg/kg 24 hours before) guinea pigs are shown to be hypersensitive and hyperresponsive to the formylated bacterial chemoattractant FMLP in vitro. Dose-response curves for chemiluminescence and beta-glucuronidase release are shifted to the left and maxima are increased. In receptor binding studies the FMLP binding capacity is shown to be enhanced in cells from endotoxin pretreated animals. FMLP (0.3 mg/kg) administered intravenously into anaesthetized and artificially ventilated guinea pigs is shown to induce neutropenia and a biphasic rise of the insufflation pressure. This response is exaggerated in endotoxin pretreated animals. The initial elevation of the airway resistance is cyclooxygenase dependent, whereas the following rise is cyclooxygenase independent and parallels the neutropenia. Histologically PMN's are shown to be trapped in the pulmonary capillaries. This is associated with an intraseptal/interstitial edema. The results illustrate a functional synergism between two important bacterial products, endotoxin and FMLP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115069     DOI: 10.1007/bf01974939

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  21 in total

1.  Acute inflammatory pulmonary reactions induced by chemotactic factors.

Authors:  U Desai; D L Kreutzer; H Showell; C V Arroyave; P A Ward
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

2.  Beta-glucuronidase of rat liver lysosomes. Purification, properties, subunits.

Authors:  P D Stahl; O Touster
Journal:  J Biol Chem       Date:  1971-09-10       Impact factor: 5.157

3.  Formylated chemotactic peptides can mimic the secondary, provoking endotoxin injection in the generalized Shwartzman reaction.

Authors:  J Fehr; C Dahinden; R Russi
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

4.  Degranulating stimuli increase the availability of receptors on human neutrophils for the chemoattractant f-met-leu-phe.

Authors:  M P Fletcher; J I Gallin
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

5.  Effects of F-met-leu-phe and zymosan-activated serum on rat neutrophils in vivo.

Authors:  R B Gilbertsen; G W Carter; D J Quinn
Journal:  J Reticuloendothel Soc       Date:  1980-05

6.  Bronchoconstriction induced by N-formyl-methionyl-leucyl-phenylalanine in the guinea pig; involvement of arachidonic acid metabolites.

Authors:  R Hamel; A W Ford-Hutchinson; A Lord; M Cirino
Journal:  Prostaglandins       Date:  1984-07

7.  Formyl-methionyl-leucyl-phenylalanine causes bronchoconstriction in rabbits.

Authors:  N Berend; C L Armour; J L Black
Journal:  Agents Actions       Date:  1986-03

8.  Exaggerated hypotension by N-formylmethionylleucyl-phenylalanine in indomethacin pretreated rats. Role of toxic oxygen.

Authors:  U B Olsen; V Bille-Hansen
Journal:  Agents Actions       Date:  1986-03

9.  Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.

Authors:  M P Fletcher; B E Seligmann; J I Gallin
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Animal models for testing anti-inflammatory drugs for treatment of bronchial hyperreactivity in asthma.

Authors:  M J Linssen; O H Wilhelms; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1991-12-13

2.  In vivo models of lung neutrophil activation. Comparison of mice and hamsters.

Authors:  Randolph Corteling; Daniel Wyss; Alexandre Trifilieff
Journal:  BMC Pharmacol       Date:  2002-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.